Answer
They differ in licensed uses, excipients, sodium content, reconstitution equipment, concentration and handling. Substitution should follow local governance and product-specific instructions.
Sources for this answer
- FIBRYGA 1g powder and solvent for injection / infusion — Current selected SmPCemc · Summary of Product Characteristics
- Riastap 1g — Current selected SmPCemc · Summary of Product Characteristics